Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00–30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 736–750 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-3056 OCLN Gene (Band‑like Calcification with Simplified Gyration and Polymicrogyria) Genetic Test This test identifies pathogenic variants in the OCLN gene associated with band-like calcification with simplified gyration and polymicrogyria (BLC-PMG).	Whole Blood (EDTA), Extracted DNA, or FTA Card	3–4 weeks from sample receipt	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the OCLN gene", "Copy Number Variants (CNVs) within the OCLN gene"] Parameters [] Preparation ["No drug or supplement cessation is required.", "Continue all prescribed medications unless otherwise instructed by your attending physician."] Indications ["Suspected diagnosis of band-like calcification with simplified gyration and polymicrogyria (BLC-PMG)", "Family history of BLC-PMG"] Measurement technique Confirm with laboratory Codes LOINC: 94473-2 ICD-10: Q04.8 Clinical summary This test identifies pathogenic variants in the OCLN gene associated with band-like calcification with simplified gyration and polymicrogyria (BLC-PMG).
TEST-4152 OCRL Gene Dent Disease Type 2 Genetic Test This test evaluates the OCRL gene for pathogenic variants associated with X-linked Dent disease type 2.	Whole Blood, Extracted DNA, or FTA Card Blood Spot	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the OCRL gene", "Single nucleotide variants", "Small insertions/deletions", "Exon-level copy number changes"] Parameters [] Preparation ["No special physical preparation is needed for the blood draw.", "Bring a list of all current medications to the counselling session."] Indications ["Suspected Dent disease type 2 based on clinical presentation", "Family history of Dent disease type 2", "Need for definitive genetic diagnosis"] Measurement technique Confirm with laboratory Codes LOINC: 60777-8 ICD-10: N25.89, N15.1 Clinical summary This test evaluates the OCRL gene for pathogenic variants associated with X-linked Dent disease type 2.
TEST-4846 OCRL Gene Sequencing Test for Lowe Oculocerebrorenal Syndrome This test evaluates the entire OCRL gene for pathogenic variants associated with Lowe oculocerebrorenal syndrome.	Whole Blood (Peripheral)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the OCRL gene", "Exons and splice sites of the OCRL gene"] Parameters [] Preparation ["No special preparation needed", "Prior genetic counseling is advised"] Indications ["Suspected Lowe oculocerebrorenal syndrome based on clinical features", "Family history of Lowe syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 55217-9 ICD-10: Q87.89 Clinical summary This test evaluates the entire OCRL gene for pathogenic variants associated with Lowe oculocerebrorenal syndrome.
TEST-2754 OLIGOCLONAL BANDS IgG CSF Test This test detects the presence of unique IgG bands in cerebrospinal fluid, indicating intrathecal antibody synthesis.	Cerebrospinal Fluid (CSF)	Next day (sample by 9 am → report following day)	900.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Immunoglobulin G (IgG) bands in CSF", "Intrathecal antibody synthesis"] Parameters [] Preparation ["Inform physician about blood-thinning medications", "Arrive with Emirates ID and insurance card"] Indications ["Suspected multiple sclerosis", "Evaluation of inflammatory neurological disorders"] Measurement technique Confirm with laboratory Codes LOINC: 5083-8 ICD-10: R83.0 Clinical summary This test detects the presence of unique IgG bands in cerebrospinal fluid, indicating intrathecal antibody synthesis.
TEST-6028 OPA3 Gene (3-Methylglutaconic Aciduria Type III) Genetic Test This genetic test analyzes the OPA3 gene to identify mutations causing 3-Methylglutaconic Aciduria Type III (Costeff syndrome). It provides a definitive diagnosis by detecting path...	Whole blood, extracted DNA, or FTA card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the OPA3 gene", "Presence of mutations associated with 3-Methylglutaconic Aciduria Type III"] Parameters [] Preparation ["No specific fasting required for blood draw", "Inform the phlebotomist of any medications being taken"] Indications ["Individuals with clinical features suggestive of 3-Methylglutaconic Aciduria Type III", "Carrier screening for family members of affected individuals", "Prenatal diagnosis in high-risk pregnancies", "Confirmation of diagnosis after abnormal biochemical screening"] Measurement technique Confirm with laboratory Codes LOINC: 94222-1 ICD-10: E71.11 Clinical summary This genetic test analyzes the OPA3 gene to identify mutations causing 3-Methylglutaconic Aciduria Type III (Costeff syndrome). It provides a definitive diagnosis by detecting pathogenic variants.
TEST-2604 ORC4 Gene Meier-Gorlin Syndrome Type 2 Genetic Test This test identifies pathogenic variants in the ORC4 gene, which are associated with Meier-Gorlin syndrome type 2, a rare form of primordial dwarfism.	Whole Blood, Extracted DNA, or One-Drop Blood on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the ORC4 gene", "Single-nucleotide variants", "Small insertions", "Small deletions"] Parameters [] Preparation ["No special fasting required", "No medication changes required"] Indications ["Clinical suspicion of Meier-Gorlin syndrome type 2", "Presence of characteristic features like microtia, patellar anomalies, and short stature"] Measurement technique Confirm with laboratory Codes LOINC: 82007-5 ICD-10: Q87.1 Clinical summary This test identifies pathogenic variants in the ORC4 gene, which are associated with Meier-Gorlin syndrome type 2, a rare form of primordial dwarfism.
TEST-2805 Organic Acids Urine Test This test quantitatively measures urinary organic acid metabolites to detect inborn errors of metabolism.	Urine (Random Midstream)	3 Days (Sample by 9 AM)	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Urinary organic acid metabolites", "Patterns of organic acid excretion"] Parameters [{"name": "Organic Acids", "reference_range": "Age-stratified reference ranges validated against DHA neonatal screening protocols"}] Preparation ["Collect a random midstream urine specimen of at least 10 mL in a sterile screw-capped container.", "Provide a detailed medication and dietary history documenting all current drugs and supplements.", "Refrigerate the specimen immediately after collection.", "Transport via cold-chain logistics."] Indications ["Investigation of inborn errors of metabolism (IEMs)", "Organic acidurias", "Aminoacidopathies", "Mitochondrial fatty acid oxidation disorders", "Neurotransmitter pathway defects", "DHA expanded newborn screening mandate for metabolic disorders"] Measurement technique Confirm with laboratory Codes LOINC: 49286-7 ICD-10: E70.8, E71.110, E72.8 Clinical summary This test quantitatively measures urinary organic acid metabolites to detect inborn errors of metabolism.
TEST-2830 Orotic Acid Test This diagnostic test evaluates urinary orotic acid concentration to identify potential urea cycle defects and hereditary orotic aciduria.	Random Urine	4 working days	800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Urinary Orotic Acid Concentration"] Parameters [{"name": "Orotic Acid", "reference_range": null}] Preparation ["Fast for 2–3 hours after the last feed", "Collect at least 15 mL of urine", "Refrigerate sample immediately"] Indications ["Suspected urea cycle disorder", "Suspected Ornithine Transcarbamylase (OTC) deficiency", "Suspected hereditary orotic aciduria", "Paediatric metabolic screening", "Therapeutic monitoring"] Measurement technique Confirm with laboratory Codes LOINC: 14634-8 ICD-10: E72.4 Clinical summary This diagnostic test evaluates urinary orotic acid concentration to identify potential urea cycle defects and hereditary orotic aciduria.
TEST-2840 OsteoScreen Panel (Bone Profile) Test This diagnostic test evaluates bone turnover by measuring markers of bone formation and resorption.	Serum	Same-day processing; digital report within 24 hours	850.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Bone formation (P1NP)", "Bone resorption (Beta-CTX)", "Skeletal metabolism"] Parameters [{"name": "P1NP (Procollagen Type I N-terminal Propeptide)", "reference_range": null}, {"name": "Beta-CTX (C-terminal Telopeptide)", "reference_range": null}] Preparation ["Fasting for 8-12 hours", "Collect sample between 8:00–10:00 AM"] Indications ["Diagnosis of osteoporosis or osteopenia", "Monitoring anti-resorptive or bone-forming therapy", "Assessment of fracture risk", "Evaluation of metabolic bone disease"] Measurement technique Confirm with laboratory Codes LOINC: 24320-4 ICD-10: Z13.820 Clinical summary This diagnostic test evaluates bone turnover by measuring markers of bone formation and resorption.
TEST-4691 OSTM1 Gene Osteopetrosis, Autosomal Recessive Type 5 Genetic Test This diagnostic test evaluates the OSTM1 gene for pathogenic variants associated with autosomal recessive osteopetrosis type 5.	Peripheral Whole Blood or FTA Card Blood Spot	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the OSTM1 gene", "Coding region and splice sites of the OSTM1 gene"] Parameters [] Preparation ["Genetic counseling session mandatory before sample collection", "Do not discontinue prescribed medication without consulting your doctor"] Indications ["Clinical suspicion of autosomal recessive osteopetrosis type 5", "Family history of osteopetrosis", "Need for carrier screening in family members", "Guiding treatment decisions (e.g., hematopoietic stem cell transplantation)"] Measurement technique Confirm with laboratory Codes LOINC: 93733-7 ICD-10: Q78.2, Z15.89, D81.9 Clinical summary This diagnostic test evaluates the OSTM1 gene for pathogenic variants associated with autosomal recessive osteopetrosis type 5.
TEST-5905 OTC Gene Ornithine Transcarbamylase Deficiency Genetic Test This test analyzes the OTC gene for pathogenic variants associated with Ornithine Transcarbamylase Deficiency.	Whole Blood (EDTA) or Dried Blood Spot (FTA Card)	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the OTC gene", "Single nucleotide variants (SNVs)", "Insertions/deletions (indels)", "Copy number variations (CNVs)"] Parameters [] Preparation ["No specific fasting required", "Do not discontinue prescribed medication without physician instruction"] Indications ["Suspected Ornithine Transcarbamylase Deficiency", "Carrier screening", "Family planning", "Prenatal diagnosis", "Preimplantation genetic testing (PGT)"] Measurement technique Confirm with laboratory Codes LOINC: 92815-3 ICD-10: E72.4, E72.2, E72.9 Clinical summary This test analyzes the OTC gene for pathogenic variants associated with Ornithine Transcarbamylase Deficiency.
TEST-2819 Ovarian Cancer Panel Test This diagnostic test evaluates key tumour biomarkers (CA-125, HE4) and calculates the ROMA index to assess the risk of ovarian malignancy.	Blood (Serum/Plasma)	Same-day reporting (samples received by 9:00 AM)	650.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["CA-125", "HE4", "ROMA Index"] Parameters [{"name": "CA-125", "reference_range": null}, {"name": "HE4", "reference_range": null}, {"name": "ROMA Index", "reference_range": null}] Preparation ["No fasting or special preparation is required", "Avoid high-dose biotin supplements for 24 hours prior to sampling", "Continue all prescribed medications unless advised otherwise by your physician"] Indications ["Evaluation of pelvic masses", "Risk assessment for ovarian cancer", "Monitoring response to ovarian cancer treatment"] Measurement technique Confirm with laboratory Codes LOINC: 10383-7 ICD-10: C56, Z12.73 Clinical summary This diagnostic test evaluates key tumour biomarkers (CA-125, HE4) and calculates the ROMA index to assess the risk of ovarian malignancy.
TEST-2844 Ovarian Reserve Panel Test This diagnostic test evaluates ovarian function and remaining egg supply by measuring key hormone levels.	Serum	Same-day reporting (sample by 9 AM)	750.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Anti-Müllerian Hormone (AMH)", "Follicle-Stimulating Hormone (FSH)", "Estradiol (E2)", "Ovarian follicular pool", "Hypothalamic-pituitary-ovarian axis function"] Parameters [{"name": "Anti-Müllerian Hormone (AMH)", "reference_range": null}, {"name": "Follicle-Stimulating Hormone (FSH)", "reference_range": null}, {"name": "Estradiol (E2)", "reference_range": null}] Preparation ["Specify cycle day (Day 2, 3, or 4 recommended for FSH/E2)", "Disclose all hormonal medications", "Consider a 4-6 week washout period for hormonal contraceptives if baseline assessment is needed"] Indications ["Fertility planning", "Perimenopause staging", "Pre-IVF workup", "Evaluation of ovarian ageing", "Diagnosis of PCOS contributions", "Monitoring response to fertility treatments"] Measurement technique Confirm with laboratory Codes LOINC: 87688-4 ICD-10: E28.8, E28.9, Z31.41 Clinical summary This diagnostic test evaluates ovarian function and remaining egg supply by measuring key hormone levels.
TEST-2850 Oxcarbazepine Metabolite Test This test measures the concentration of 10-hydroxycarbazepine (MHD), the active metabolite of oxcarbazepine, in a blood sample.	Peripheral Blood (Serum/Plasma)	10 Working Days (Mon–Sat processing)	1,000.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["10-Hydroxycarbazepine (MHD) concentration", "Therapeutic drug exposure"] Parameters [{"name": "10-Hydroxycarbazepine (MHD)", "reference_range": "10–35 mg/L (Therapeutic range, may vary based on age, seizure type, renal function)"}] Preparation ["Collect blood sample immediately before the next scheduled dose (trough level)", "Inform nurse of all medications, including OTC and supplements"] Indications ["Monitoring therapeutic drug levels in epilepsy patients", "Assessing adherence to oxcarbazepine therapy", "Guiding dose adjustments based on individual metabolism", "Investigating potential drug interactions"] Measurement technique Confirm with laboratory Codes LOINC: 35368-2 ICD-10: R79.8, G40.909 Clinical summary This test measures the concentration of 10-hydroxycarbazepine (MHD), the active metabolite of oxcarbazepine, in a blood sample.
TEST-5813 OXCT1 Gene (Succinyl-CoA:3-Oxoacid CoA Transferase Deficiency) Genetic Test This genetic test identifies pathogenic variants in the OXCT1 gene associated with Succinyl-CoA:3-Oxoacid CoA Transferase (SCOT) deficiency.	Whole blood, extracted DNA, or FTA card blood spot	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the OXCT1 gene", "Single-nucleotide variants", "Copy number changes"] Parameters [] Preparation ["Pre-test genetic counseling session required", "Do not perform elective blood draw during acute metabolic crisis", "Stabilize patient before specimen collection if in crisis"] Indications ["Recurrent unexplained ketoacidosis", "Family history of SCOT deficiency", "Consanguineous backgrounds (Emirati, South Asian heritage)", "Pre-test genetic counseling documentation"] Measurement technique Confirm with laboratory Codes LOINC: 79474-8 ICD-10: E88.8, Z13.228, Z15.89 Clinical summary This genetic test identifies pathogenic variants in the OXCT1 gene associated with Succinyl-CoA:3-Oxoacid CoA Transferase (SCOT) deficiency.

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area

Biochemistry tests in Dubai & UAE

Biochemistry test prices

Biochemistry: overview

Use the test details as a conversation starter

Related Biochemistry categories